Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2006-12-04
2008-10-21
Witherspoon, Sikarl A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S086000, C564S194000, C514S538000, C514S553000, C514S567000, C514S591000, C514S602000, C514S630000
Reexamination Certificate
active
07439393
ABSTRACT:
The invention relates to 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; and salts and solvates thereof, including those which are pharmaceutically acceptable, along with formulations thereof, combinations thereof, and methods for the treatment or prophylaxis of mammals by administering such compounds.
REFERENCES:
patent: 2140800 (1938-12-01), Leemans
patent: 3994974 (1976-11-01), Murakami et al.
patent: 4730008 (1988-03-01), Skidmore et al.
patent: 4853381 (1989-08-01), Finch et al.
patent: 4853382 (1989-08-01), Skidmore et al.
patent: 4908386 (1990-03-01), Finch et al.
patent: 4937268 (1990-06-01), Skidmore et al.
patent: 4963564 (1990-10-01), Skidmore et al.
patent: 4990505 (1991-02-01), Skidmore et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 4997986 (1991-03-01), Mitchell et al.
patent: 5066678 (1991-11-01), Skidmore et al.
patent: 5091422 (1992-02-01), Skidmore et al.
patent: 5099068 (1992-03-01), Mitchell et al.
patent: 5109023 (1992-04-01), Mitchell et al.
patent: 5126375 (1992-06-01), Skidmore et al.
patent: 5225445 (1993-07-01), Skidmore et al.
patent: 5243076 (1993-09-01), Skidmore et al.
patent: 5283262 (1994-02-01), Mitchell et al.
patent: 5290815 (1994-03-01), Johnson et al.
patent: 5393774 (1995-02-01), Pieper et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 5998428 (1999-12-01), Barnette et al.
patent: 7135600 (2006-11-01), Biggadike et al.
patent: 3513885 (1985-10-01), None
patent: 3524990 (1986-01-01), None
patent: 4028398 (1992-03-01), None
patent: 0069715 (1983-01-01), None
patent: 69715 (1983-01-01), None
patent: 162576 (1985-11-01), None
patent: 220054 (1987-04-01), None
patent: 220878 (1987-05-01), None
patent: 223410 (1987-05-01), None
patent: 0286242 (1988-10-01), None
patent: 286242 (1988-10-01), None
patent: 303465 (1989-02-01), None
patent: 0317206 (1989-05-01), None
patent: 0416951 (1991-01-01), None
patent: 223671 (1991-11-01), None
patent: 0401966 (1994-01-01), None
patent: 0947498 (1999-10-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2140800 (1984-12-01), None
patent: 2159151 (1985-11-01), None
patent: 2162842 (1986-02-01), None
patent: 2169265 (1986-07-01), None
patent: 2176476 (1986-12-01), None
patent: 2178965 (1987-02-01), None
patent: 2230523 (1990-10-01), None
patent: 2242134 (1991-09-01), None
patent: WO 95/01170 (1995-01-01), None
patent: WO 95/19336 (1995-07-01), None
patent: WO 99/16766 (1999-04-01), None
patent: WO 99/47505 (1999-09-01), None
patent: 0051599 (2000-09-01), None
patent: WO 01/04118 (2001-01-01), None
patent: WO 01/13953 (2001-03-01), None
patent: 02066422 (2002-08-01), None
patent: 02070490 (2002-09-01), None
patent: WO2004/071388 (2004-08-01), None
Fuji et al., “Novel phosphodieslerase 4 inhibitor T-440 reverses and prevents human bronchial contraction induced by allergen,”J Pharmacol Exp Ther284(1):162 (1998).
Landells et al., “Oral administration of the phosphodiesterase (PDE)4 inhibitor. V11294A inhibits ex-vivo agonist-induced-cell activation, ”Eur Resp J(Iunnu Cong Eur Resp Soc. Geneva) 12(Suppl. 28) Abst P2393 (Sep. 1998).
McHale et al., “Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast,”Mol Pharmacol39:109-113 (1991).
Nicholson et al., “Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.”Trends Pharmacol Sci12:19-27 (1991).
Torphy et al., “Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis,”Mol. Pharmacol39:376-384 (1991).
Thornber, “Isosterism and molecular modification in drug design,”Chemical Society Reviews:8(4)563-580 (1979).
U.S. Appl. No. 10/522,321, filed Jul. 6, 2005.
U.S. Appl. No. 11/207,667, filed Aug. 19, 2005.
U.S. Appl. No. 11/426,657, filed Jun. 27, 2006.
U.S. Appl. No. 11/426,661, filed Jun. 27, 2006.
Official Action, date mailed Mar. 15, 2007, U.S. Appl. No. 10/522,321.
Dr. Meyer Magarici; Riesgossobre broncodilatadors; SVMS; Nov. 29, 2005.
Drug Bank Chemical Compound Query Result Re Salmeterol; Jul. 31, 2000.
D. Iakovidis, et al.; “Synthesis and beta-andrenoceptor agonist properties of (+/-)-1-(3′,4′-dihydroxyphenoxy)-3-(3″,4″-dimethooxyphenyl)ethylamino-2-propanol hydrochloride, (+/-)-(RO363.HCI, and the (2S)-(-)-isomer”; European Journal of Medicinal Chemistry; Jun. 6, 1999; vol. 34, No. 6; pp. 539-548.
Robert Hett, et al., “Enantioselective synthesis of salmeterol via asymmetric borane reduction”; Tetrahedron Letters; 1994; vol. 35, No. 50.
U.S. Appl. No. 11/207,967, filed Aug. 19, 2005.
U.S. Appl. No. 11/207,967, final office action dated Jun. 19, 2007.
U.S. Appl. No. 11/426,657, non-final office action dated Jun. 25, 2007.
U.S. Appl. No. 11/207,967, non-final office action dated Jan. 11, 2007.
U.S. Appl. No. 11/426,661, non-final office action dated Jan. 12, 2007.
U.S. Appl. No. 11/426,661, non-final office action dated Jul. 5, 2007.
U.S. Appl. No. 11/426,657, non-final office action dated Jan. 12, 2007.
Box Philip Charles
Coe Diane Mary
Looker Brian Edgar
Mann Inderjit Singh
Procopiou Panayiotis Alexandrou
Glaxo Group Limited
Smith Robert J.
Witherspoon Sikarl A
LandOfFree
Phenethanolamine derivatives for treatment of respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenethanolamine derivatives for treatment of respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenethanolamine derivatives for treatment of respiratory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4014851